Screener
Ironwood Pharmaceuticals IRWD Total Revenue
Total Revenue at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Ironwood Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091987
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Revenues: | ||||
| Collaborative arrangements revenue | $113,041 | $85,239 | $219,547 | $126,382 |
| Total revenues | 113,041 | 85,239 | 219,547 | 126,382 |
| Costs and expenses: | ||||
| Research and development | 22,421 | 23,373 | 44,361 | 50,805 |
| Selling, general and administrative | 11,313 | 16,795 | 23,346 | 41,055 |
| Restructuring, net | — | (250) | (40) | 18,309 |
| Total costs and expenses | 33,734 | 39,918 | 67,667 | 110,169 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Ironwood Pharmaceuticals's total revenue?
- Ironwood Pharmaceuticals (IRWD) reported total revenue of $113.04M in Q2 2026.
- How has Ironwood Pharmaceuticals's total revenue changed year-over-year?
- Ironwood Pharmaceuticals's total revenue increased by 32.6% year-over-year, from $85.24M to $113.04M.
- What is the long-term trend for Ironwood Pharmaceuticals's total revenue?
- Over 4 years (2021 to 2025), Ironwood Pharmaceuticals's total revenue has grown at a -8.0% compound annual growth rate (CAGR), from $413.75M to $296.15M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Ironwood Pharmaceuticals's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude